211 related articles for article (PubMed ID: 31146140)
1. Twenty years of Lithium pharmacogenetics: A systematic review.
Pagani R; Gasparini A; Ielmini M; Caselli I; Poloni N; Ferrari M; Marino F; Callegari C
Psychiatry Res; 2019 Aug; 278():42-50. PubMed ID: 31146140
[TBL] [Abstract][Full Text] [Related]
2. Predicting response to lithium in bipolar disorder: a critical review of pharmacogenetic studies.
Smith DJ; Evans R; Craddock N
J Ment Health; 2010 Apr; 19(2):142-56. PubMed ID: 20433322
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of lithium response in bipolar disorder.
McCarthy MJ; Leckband SG; Kelsoe JR
Pharmacogenomics; 2010 Oct; 11(10):1439-65. PubMed ID: 21047205
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomic aspects of bipolar disorder: An update.
Budde M; Degner D; Brockmöller J; Schulze TG
Eur Neuropsychopharmacol; 2017 Jun; 27(6):599-609. PubMed ID: 28342679
[TBL] [Abstract][Full Text] [Related]
5. Can the response to mood stabilizers be predicted in bipolar disorder?
Geoffroy PA; Bellivier F; Leboyer M; Etain B
Front Biosci (Elite Ed); 2014 Jan; 6(1):120-38. PubMed ID: 24389147
[TBL] [Abstract][Full Text] [Related]
6. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.
Pisanu C; Heilbronner U; Squassina A
Mol Diagn Ther; 2018 Aug; 22(4):409-420. PubMed ID: 29790107
[TBL] [Abstract][Full Text] [Related]
7. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
[TBL] [Abstract][Full Text] [Related]
8. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.
Alda M
Mol Psychiatry; 2015 Jun; 20(6):661-70. PubMed ID: 25687772
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic aspects of bipolar disorder.
Alda M
Pharmacogenomics; 2003 Jan; 4(1):35-40. PubMed ID: 12517284
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of lithium response in bipolar disorder.
Alda M
J Psychiatry Neurosci; 1999 Mar; 24(2):154-8. PubMed ID: 10212559
[TBL] [Abstract][Full Text] [Related]
12. Lithium Pharmacogenetics: Where Do We Stand?
Pisanu C; Melis C; Squassina A
Drug Dev Res; 2016 Nov; 77(7):368-373. PubMed ID: 27633500
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics and bipolar disorder.
Mamdani F; Groisman IJ; Alda M; Turecki G
Pharmacogenomics J; 2004; 4(3):161-70. PubMed ID: 15079146
[TBL] [Abstract][Full Text] [Related]
14. Lithium for maintenance treatment of mood disorders.
Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
[TBL] [Abstract][Full Text] [Related]
15. Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment.
Pisanu C; Congiu D; Manchia M; Caria P; Cocco C; Dettori T; Frau DV; Manca E; Meloni A; Nieddu M; Noli B; Pinna F; Robledo R; Sogos V; Ferri GL; Carpiniello B; Vanni R; Bocchetta A; Severino G; Ardau R; Chillotti C; Zompo MD; Squassina A
Pharmacogenomics; 2020 Jun; 21(8):533-540. PubMed ID: 32372689
[No Abstract] [Full Text] [Related]
16. Pharmacogenetics of antidepressants, mood stabilizers, and antipsychotics in diverse human populations.
Murphy E; McMahon FJ
Discov Med; 2013 Sep; 16(87):113-22. PubMed ID: 23998447
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of bipolar disorder.
Mansour HA; Alda M; Nimgaonkar VL
Curr Psychiatry Rep; 2002 Apr; 4(2):117-23. PubMed ID: 11914172
[TBL] [Abstract][Full Text] [Related]
18. Maintenance therapies in bipolar disorder: focus on randomized controlled trials.
Muzina DJ; Calabrese JR
Aust N Z J Psychiatry; 2005 Aug; 39(8):652-61. PubMed ID: 16050919
[TBL] [Abstract][Full Text] [Related]
19. Molecular actions and clinical pharmacogenetics of lithium therapy.
Can A; Schulze TG; Gould TD
Pharmacol Biochem Behav; 2014 Aug; 123():3-16. PubMed ID: 24534415
[TBL] [Abstract][Full Text] [Related]
20. Genetics of Lithium Response in Bipolar Disorder.
Papiol S; Schulze TG; Alda M
Pharmacopsychiatry; 2018 Sep; 51(5):206-211. PubMed ID: 29579760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]